Fairvalue-Calculator Fairvalue-Calculator
EN DE

Qingdao Vland Biotech INC. (603739) Fair Value & Analysis

Healthcare · CN · Market cap 3.1B CNY

Price¥12.22
Fair Value¥6.07
Upside-50.3%
Quality89/100
Evidence: Medium Range ¥3.95 – ¥7.59

Fair value as of: Jun 24, 2026

Analysis

Qingdao Vland Biotech INC. (603739) currently trades at ¥12.22, while our model-based Fair Value estimate is ¥6.07 — implying the stock looks roughly 50.3% overvalued today. We read business quality at 89/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

Qingdao Vland Biotech INC. engages in the research and development, production, and sale of enzyme preparations, microecological preparations, and animal health products in China and internationally. It offers feed, industrial, and food enzymes; and probiotics, including aquaculture premixes, health products, and animal and plant probiotics. The company also offers animal vaccines and biological products, such as live and inactivated, and poultry and swine vaccines, as well as egg yolk antibodies; poultry drugs comprising anti-parastic, antiviral, and nutritional drugs, as well as disinfectants; and traditional Chinese veterinary medicines for scale and avian breeding, livestock, and laying hens. It serves agriculture, animal husbandry, textile, pulp and paper, health care, laundry, biofuel, household cleaning and detergents, food, animal feed, biofuel, environmental protection, washing, and other industries. Qingdao Vland Biotech INC. was incorporated in 2005 and is headquartered i…

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -32% Regeneron Pharmaceuticals, Inc (REGN) -4% UCB SA (UCB) -23% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +1% Alnylam Pharmaceuticals, Inc (ALNY) -82%

Frequently asked questions

Is Qingdao Vland Biotech INC. (603739) undervalued?
As of Jun 24, 2026, our model estimates a fair value of ¥6.07 versus a price of ¥12.22 — about −50% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 603739?
Our 21-model fair value for Qingdao Vland Biotech INC. is ¥6.07 (as of Jun 24, 2026), built from audited fundamentals. The current price is ¥12.22.
What is the quality score of 603739?
Qingdao Vland Biotech INC. has a Quality Score of 89/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.